Loratadine Activase Pharmaceuticals (Loratadine)

Loratadine selectively binds to peripheral H1 histamine receptors, preventing histamine from attaching and activating the receptor cascade that leads to vasodilation, increased vascular permeability, and sensory nerve stimulation. Because it does not readily cross the blood‑brain barrier, it provides antihistaminic effects without significant sedation. This antagonism reduces the classic allergy symptoms of itching, swelling, and mucus production.

The appropriate dose of loratadine is determined by the prescribing healthcare professional based on the patient’s age, condition and clinical response. In most regions, adults and children over a certain age are advised to take one tablet once daily, while pediatric dosing may differ. Patients should follow the specific instructions provided on the label or by their clinician and should not adjust the dose without medical advice.

Safety data for loratadine in pregnancy are limited, and it is classified as a category where the benefits and risks must be weighed by a healthcare provider. For breastfeeding mothers, only small amounts are excreted in milk, and the decision to use loratadine should consider potential effects on the infant. Consultation with a physician or obstetrician is recommended before starting therapy.

To request a supply, visit the product page on gnhindia.com, enter the desired quantity, and submit the enquiry form. GNH India works with hospitals, pharmacies and procurement teams worldwide, reviewing trade or institutional credentials before providing a quotation. The sales team will then respond with pricing, availability, shipping details (including any required temperature control) and assistance with import documentation.

Compared with first‑generation antihistamines such as diphenhydramine, loratadine offers similar efficacy in relieving allergy symptoms but with considerably less sedation because it minimally penetrates the central nervous system. Among second‑generation agents, its potency and duration of action are comparable to cetirizine and fexofenadine, making it a suitable option for patients who need non‑sedating relief for daily activities.

Loratadine tablets should be stored at ambient temperature, preferably below 25 °C (77 °F). Keep the product in its original container, protect it from moisture, excessive heat and direct sunlight. Do not store in bathrooms or near kitchen appliances that generate steam. Proper storage helps maintain tablet integrity and potency throughout its shelf life.

Loratadine is taken orally, usually as a whole tablet swallowed with a glass of water. It can be taken with or without food, and the tablet should not be chewed or crushed unless specifically instructed by a pharmacist. The medication is intended for once‑daily dosing, and patients should adhere to the schedule prescribed by their healthcare provider for optimal symptom control.

Although rare, serious adverse reactions can occur, including anaphylaxis, severe skin reactions such as Stevens‑Johnson syndrome, and liver injury manifested by jaundice or elevated liver enzymes. Patients experiencing difficulty breathing, swelling of the face or throat, widespread rash, or signs of hepatic dysfunction should seek immediate medical attention. Prompt reporting of any severe symptoms helps ensure appropriate management.

Loratadine should be avoided by individuals with a known hypersensitivity to loratadine, other antihistamines, or any of the tablet’s excipients. It is also contraindicated in patients who have experienced severe reactions such as anaphylaxis to similar drugs. Children below the approved minimum age and patients with certain severe hepatic or renal impairments should not use loratadine without medical supervision.